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advanced OA cartilage correlated significantly with BMI values
of the patients (r=0.610, p<0.05). SF had higher leptin con-
centrations than the paired serum sample, while a significant
correlation was observed between serum and SF leptin levels
(r=0.672, p<0.01). In normal chondrocytes cultures (48 hrs),
leptin enhanced cell proliferation but reduced it in osteoarthritic
chondrocytes, while in long term cultures leptin had a similar
detrimental effect on chondrocytes. Furthermore, leptin induced
the production of IL-1β in long term cultures.
Conclusions: For the first time to our knowledge, using quan-
titative real-time PCR, we observed leptin and Ob-Rb mRNA
expression in chondrocytes of osteoarthritic cartilage. The ob-
served intrajoint difference in leptin and Ob-Rb mRNA expres-
sion between advanced and minimally affected knee and hip
osteoarthritic cartilage, along with the higher observed leptin
concentrations in SF than in paired serum samples indicate a
local role of leptin in joint tissues. The increased leptin’s mRNA
expression in obese compared to normal weight patients sug-
gested that mechanical overload may alter chondrocytes’ phe-
notype. Also the decrease in chondrocyte’s proliferation after
induction with leptin points toward a long term detrimental ef-
fect on cartilage, while the observed IL-1β production suggests
an inflammatory role of leptin, which may account for cartilage
degradation. Taken together our findings support the hypothesis
that leptin is involved in OA development and that may be the
missing link between biomechanical and metabolic factors in-
volved in OA. However, further studies are needed to confirm the
involvement of leptin in OA and to investigate the link between
obesity, inflammation, leptin and osteoarthritis.
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Purpose: The matrix metalloproteinase (MMP) family consists
of 23 structurally related proteases that are able to degrade a
wide range of substrates, including many components of the ex-
tracellular matrix (ECM). MMP-28 (epilysin), is a recently cloned
member of the MMP family. We have recently described MMP28
expression in cartilage with significant increase in osteoarthri-
tis. The principle level of control of MMP expression is gene
transcription. The promoter region of both human and mouse
MMP28 has been cloned and characterised. Conserved mo-
tifs were identified that could control the expression of MMP28
including a GT-box situated 300 bp upstream from the trans-
lation start site that binds both Sp1 and Sp3 proteins and
is essential for MMP28 basal expression in keratinocytes. We
showed recently that histone deacetylase inhibitors (HDACi) are
chondroprotective. Whilst HDACi downregulate expression of a
number of MMPs, a small subset are induced and this includes
MMP28.
Methods: Promoter-reporter constructs were made in pGL3 and
transiently transfected into HeLa or SW1353 cells using Fu-
Gene6. DNA-protein interaction was assessed by gel mobility
shift assay. Acetylation of Sp1 and Sp3 was probed using im-
munoprecipitation with a specific antibody and Western blotting
with an anti-(pan acetyl lysine) antibody.
Results: Transient transfection assays with deletion constructs
of the MMP28 gene promoter, showed that HDACi, including
trichostatin A (TSA), valproic acid, sodium butyrate, upregulate
transcription from the promoter via the promoter proximal GT
described above. This was confirmed using point mutants in this
site. Gel mobility shift and supershift assays using Sp1/2/3 anti-
bodies showed that Sp1 and Sp3 bind to the MMP28 promoter
via the GT-box. Using transient transfection assays with the wild
type and mutant promoters we showed that Sp1, but not Sp3,
can induce the MMP28 promoter via the GT-box. HDACi induce
transcription from the promoter via Sp1 action at this site. Sp1 is
known to interact with the histone acetyltransferase (HAT) p300
and histone deacetylase 1 (HDAC1). Forced overexpression of
either p300 or PCAF, but not CBP (all of which are known HATs),
induces the MMP28 promoter, as does siRNA knockdown of
HDAC1. Sp1 and 3 can both be acetylated and phosphory-
lated which is reported to alter their DNA-binding properties.
In immunoprecipitation experiments, the acetylation of Sp1 and
Sp3 was increased by TSA treatment. Furthermore, the ser-
ine/threonine phosphatase inhibitor, okadaic acid can block the
TSA induction of the MMP28 promoter. Oligo pulldown experi-
ments have identified a 37kD protein which specifically interacts
with the GT-box, and this is currently being identified using mass
spectrometry.
Conclusions: These results suggest that acetylation regulates
the MMP28 gene via a promoter proximal GT-box which directly
binds and is activated by Sp1. Other proteins are also involved
in mediating the induction of MMP28, including at least p300,
PCAF, HDAC1 and a currently unidentified 37kD protein.
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Purpose: We recently identified RHOB as a gene over-
expressed in OA patients. The analysis of RHOB expression
revealed allelic imbalances indicating cis-regulatory mechanisms
and indeed, a single nucleotide polymorphism (SNP) at -165
in the RHOB promoter turned out to be associated with OA.
We here investigate in detail the regulation of RHOB expres-
sion and the functional consequences of its over-expression in a
chondrosarcoma line.
Methods: Apoptosis following over-expression of RHOB in the
human chondrosarcoma line SW1353 was assayed via quantifi-
cation of cells in the sub-G1 phase of the cell cycle and con-
firmed by confocal laser microscopy. Disease association of the
variable number of tandem repeats (VNTR) polymorphism was
determined by PCR. Luziferase assays in combination with re-
porter constructs were performed to measure the various RHOB
promoter activities.
Results: The RHOB genotyping data support a recessive model
for the SNP at -165 with the homozygous genotype (G/G) con-
ferring an Odds ratio of 4.3 to develop OA. An additional VNTR
polymorphism in the promoter region shows a distinct linkage
disequilibrium (LD) with the -165 SNP whereby in the controls
the T-allele is preferentially linked to 13 tandem repeats. In con-
trast, 10 tandem repeats are preferentially linked to the G-allele in
the patients. The corresponding p values indicating the linkages
are 0.0009 and 0.0144, respectively. The SubG1-assays reveal a
7-fold higher apoptosis rate of RHOB over-expressing cells com-
pared to cells expressing the normal endogenous levels. This
increase in cells entering the sub-G1 phase is paralleled by an
apoptotic phenotype of cell shrinking and flaking.
Conclusions: Our results support the concept of OA being
the consequence of active disease processes. We show that
